Diversification and downstream: the 5 problems facing biopharma’s future By Fiona BARRY 18-Feb-2014 - Last updated on 18-Feb-2014 at 13:22 GMT Facebook Twitter Linkedin Email to a friend Biomanufacturing equipment needs innovation, said Jonathan Robinson. Join the debate in the comments below by telling us what you think will be the biggest trends and challenges in biopharmaceuticals in the coming years. Diversification Downstream innovation Facilities of the future Analytics Training a workforce Prev 1 2 3 4 5 Next
